Cercar
01/12/2023
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.
Balsa A, Díaz Del Campo Fontecha P, Silva Fernández L, Valencia Martín J, Nistal Martínez V, León Vázquez F, Hernández Hernández MV, Corominas H, Cáliz Cáliz R, Aguado García JM, Candelas Rodríguez G, Ibargoyen Roteta N, Martí Carvajal A, Plana Farras MN, Puñal Riobóo J, Park HS, Triñanes Pego Y, Villaverde García V. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reumae.2023.07.004. PMID:38008602. IF:(Q/D).
01/11/2025
Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study
De Silva, C, Díaz-Torné, C, Gamble, G, Horne, A, Doyle, A, Stamp, LK, Dalbeth, N. Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study. RHEUMATOLOGY. 2025; 64(11)DOI:10.1093/rheumatology/keaf347. PMID:40581776. IF:4.400(Q1/1D).
21/05/2025
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS
Vidal-Montal, P, Fabregat, A, Heredia, S, Bernardez, J, Magallares, BP, Gómez-Puerta, J, Frade-Sosa, B, Nolla, JM, Narváez, J. TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS. JOURNAL OF RHEUMATOLOGY. 2025; 52DOI:. PMID:. IF:3.400(Q2/3D).
01/01/2025
Gout therapy updated
McCarty, KL, Gaffo, AL, Diaz-Torne, C. Gout therapy updated. Therapeutic Advances in Musculoskeletal Disease. 2025; 17DOI:10.1177/1759720X251384584. PMID:41146690. IF:4.100(Q1/3D).